Cargando…

2235. A Collaborative Drug Therapy Management Model for the Treatment of Hepatitis C Virus (HCV) in an Urban Clinic

BACKGROUND: Direct-acting antivirals (DAAs) have changed the paradigm of HCV treatment due to high-sustained virologic response (SVR) rates and minimal adverse events. Prior authorizations, complex treatment criteria, and inadequate clinic staffing to meet demands of screening efforts may prevent ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vibhakar, Sonia, Nowicki, Diana, Huhn, Greg, Goldberg, Rebecca, Adeyemi, Oluwatoyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252939/ http://dx.doi.org/10.1093/ofid/ofy210.1888

Ejemplares similares

Factors Associated with Appropriate Hepatocellular Carcinoma (HCC) Screening Among Chronic Hepatitis C (HCV) Patients with Cirrhosis at an Urban Safety-net Hospital System
por: Cabrera, Nicolo, et al.
Publicado: (2017)

2213. Hepatitis C Virus (HCV) Care Continuum Post-implementation of Electronic Clinical Decision Support (eCDS) Tool to Increase HCV Screening Among Baby Boomers in Large Urban Health System
por: Armstrong, Hilary, et al.
Publicado: (2018)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic
por: Sansom, Sarah E, et al.
Publicado: (2019)

2208. Fibrosis Surveillance by Transient Elastography in Patients with Untreated Hepatitis C Infection
por: Adeyemi, Oluwatoyin, et al.
Publicado: (2018)

2235. Characterization of the Adult Sepsis Treatment Guideline Utilization Within the Emergency Department at an Academic Medical Center
por: Berg, Deanna M, et al.
Publicado: (2023)

High Incidence of Hepatitis C Virus (HCV) Infection among an Urban Emergency Department (ED) Patients. 2003–2016.
por: Patel, Anuj, et al.
Publicado: (2017)

A search for the $\xi$(2235) in $\overline{p}p \rightarrow \pi^{-}\pi^{+}$
por: Hasan, A, et al.
Publicado: (1996)

576. Continuing Disparities in Virologic Control for People Living with HIV (PLWH) Receiving Care at a Large, Urban, Safety-Net Clinic
por: Lubelchek, Ronald, et al.
Publicado: (2018)

928. Barriers to Hepatitis C Elimination in an Urban Clinic Offering Integrated HIV/HCV Treatment
por: Correia, Lauren A, et al.
Publicado: (2020)

Implementation of a Comprehensive Hepatitis C Virus (HCV) Treatment Program in Metro-Detroit
por: Awali, Reda, et al.
Publicado: (2017)

603. Multi-morbidity and Impaired CD4/CD8 Ratios in Older Adults with Well-Controlled HIV
por: Adeyemi, Oluwatoyin, et al.
Publicado: (2018)

362. Hepatitis C Virus (HCV) Co-Infection in Women Living with Human Immunodeficiency Virus (HIV) in Northwest Louisiana
por: Mohammed, Ethar, et al.
Publicado: (2019)

1073. The Time is Now for Rapid Initiation of Hepatitis C Virus (HCV) Treatment
por: Radford, Colton P, et al.
Publicado: (2020)

2252. Predictors of Cardiovascular Outcomes in Older HIV-Infected Patients: CORE50 Cohort 10-Year Follow-up
por: Sansom, Sarah, et al.
Publicado: (2018)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users
por: Oprea, Cristiana, et al.
Publicado: (2014)

2235 15N-Leucine transport across the blood brain barrier is significantly impaired in the glutamine synthetase-inhibited brain
por: Gruenbaum, Shaun E., et al.
Publicado: (2018)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

2215. Polymerase Chain Reaction (PCR) for Detection of Vertically Acquired Hepatitis C Virus (HCV) Infection in Early Infancy
por: Honegger, Jonathan, et al.
Publicado: (2018)

355. Barriers for Hepatitis C Elimination in HIV/HCV Coinfected Patients
por: Espinoza, Joe, et al.
Publicado: (2019)

Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
por: Kåberg, M., et al.
Publicado: (2022)

2216. Hepatitis C Treatment Wanted Yet Not Received: Barriers to Receiving HCV Treatment Among People Who Inject Drugs
por: Kapadia, Shashi, et al.
Publicado: (2018)

2941. Racial and Ethnic Disparities in the Care Cascade for Children with Perinatal Hepatitis C Virus (HCV) infection in the United States (US)
por: Rose Curtis, Megan, et al.
Publicado: (2023)

2206. In a Non-urban Hepatitis C Cohort, Linkage to an Infectious Diseases Clinic with Embedded Services Is Associated with Better Outcomes Than Linkage to a Gastroenterology HCV Clinic Without These Services for Those with Substance Abuse
por: Sherbuk, Jacqueline, et al.
Publicado: (2018)

Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic
por: Patel, Manish, et al.
Publicado: (2017)

Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications
por: Kaur, Kirpal, et al.
Publicado: (2015)

315. Prenatal Hepatitis C Viral (HCV) Screening Practices and HCV-Associated Fetal, Neonatal and Pregnancy Outcomes in a Large Regional Healthcare System
por: Adhikari, Tripti, et al.
Publicado: (2019)

The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
por: De Comarmond, Charles, et al.
Publicado: (2017)

Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
por: Nutt, Jamie, et al.
Publicado: (2017)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution
por: Huhn, Gregory D, et al.
Publicado: (2010)

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
por: Patel, Sonia Vibhakar, et al.
Publicado: (2020)

Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services
por: Strauss, Shiela M, et al.
Publicado: (2007)

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
por: Chevaliez, Stéphane, et al.
Publicado: (2009)

1599. Real-World Efficacy of Long-Acting Cabotegravir and Rilpivirine in an Urban HIV Clinic
por: Perez, Sarah, et al.
Publicado: (2023)

Epidemiology of Hepatitis C Virus (HCV) Infection
por: Sy, Theodore, et al.
Publicado: (2006)

295. South Carolina Hepatitis C Telehealth Initiative (SCHTI): Increasing Access to HCV Care
por: Derrick, Caroline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7uq41bjitd191h36038bj0sdm8